Could run to 11c easily, which is a PE of 20 from last FY, or likely 10-15 from this year’s PE. Still cheap at that price given unknown lithium upside.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%
